Squarepoint’s Ascendis Pharma A/S ASND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-6,474
| Closed | -$1.45M | – | 4258 |
|
|
2025
Q4 | $1.38M | Buy |
6,474
+5,271
| +438% | +$1.09M | ﹤0.01% | 2344 |
|
|
2025
Q3 | $239K | Sell |
1,203
-3,994
| -77% | -$745K | ﹤0.01% | 3823 |
|
|
2025
Q2 | $897K | Buy |
+5,197
| New | +$847K | ﹤0.01% | 2762 |
|
|
2024
Q1 | – | Sell |
-5,881
| Closed | -$741K | – | 4006 |
|
|
2023
Q4 | $741K | Buy |
+5,881
| New | +$586K | ﹤0.01% | 2734 |
|
|
2023
Q3 | – | Sell |
-11,125
| Closed | -$993K | – | 3764 |
|
|
2023
Q2 | $993K | Buy |
+11,125
| New | +$968K | 0.01% | 2168 |
|
|
2022
Q4 | – | Sell |
-17,329
| Closed | -$1.79M | – | 3170 |
|
|
2022
Q3 | $1.79M | Buy |
17,329
+13,609
| +366% | +$1.29M | 0.02% | 1393 |
|
|
2022
Q2 | $346K | Buy |
+3,720
| New | +$351K | ﹤0.01% | 2213 |
|
|
2022
Q1 | – | Sell |
-1,826
| Closed | -$246K | – | 2795 |
|
|
2021
Q4 | $246K | Sell |
1,826
-2,082
| -53% | -$310K | ﹤0.01% | 2567 |
|
|
2021
Q3 | $623K | Sell |
3,908
-2,569
| -40% | -$352K | ﹤0.01% | 1828 |
|
|
2021
Q2 | $852K | Buy |
+6,477
| New | +$863K | 0.01% | 1754 |
|
|
2020
Q4 | – | Sell |
-3,166
| Closed | -$489K | – | 2897 |
|
|
2020
Q3 | $489K | Buy |
+3,166
| New | +$455K | 0.01% | 1452 |
|
|
2020
Q2 | – | Sell |
-3,420
| Closed | -$385K | – | 2215 |
|
|
2020
Q1 | $385K | Buy |
+3,420
| New | +$444K | 0.01% | 1175 |
|
|
2019
Q2 | – | Sell |
-7,379
| Closed | -$869K | – | 2357 |
|
|
2019
Q1 | $869K | Buy |
7,379
+4,119
| +126% | +$361K | 0.01% | 1175 |
|
|
2018
Q4 | $204K | Buy |
+3,260
| New | +$205K | ﹤0.01% | 1676 |
|
|
2018
Q3 | – | Sell |
-4,300
| Closed | -$286K | – | 1973 |
|
|
2018
Q2 | $286K | Sell |
4,300
-1,200
| -22% | -$78.9K | ﹤0.01% | 1398 |
|
|
2018
Q1 | $360K | Buy |
+5,500
| New | +$309K | 0.01% | 1227 |
|
Other funds holding ASND
RCM
ACA
